Daniel
Carpio López
Pfizer (United States)
Nueva York, Estados UnidosPublications in collaboration with researchers from Pfizer (United States) (1)
2024
-
Clinical settings with tofacitinib in ulcerative colitis
Revista Espanola de Enfermedades Digestivas, Vol. 116, Núm. 9, pp. 484-492